Albemarle Corporation
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hy…
Chemicals - Specialty
US, Charlotte [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -3452.67 | -967.51 | -27.23 | |
| Graham Fair Price | -93.04 | 6.79 | 97.46 | |
| PEG | 68240.93 | -15.43 | 0.02 | |
| Price/Book | -26.97 | 1.32 | 1.80 | |
| Price/Cash Flow | -45.43 | -31.52 | -21.67 | |
| Prices/Earnings | 22478.68 | 1549.46 | -6.86 | |
| Price/Sales | 54.95 | 11.15 | 7.20 | |
| Price/FCF | -45.43 | -31.52 | -21.67 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Bad
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -90.97 | 0.03 | -0.29 | |
| Operating Margin | 72.11 | -0.11 | -0.38 | |
| ROA | -99.62 | < 0.005 | -0.03 | |
| ROE | -0.07 | < 0.005 | -99.68 | |
| ROIC | -0.07 | < 0.005 | 87.43 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.15 | 0.18 | -16.38 | |
| Dividends QOQ | < 0.005 | < 0.005 | 6672.26 | |
| EBIT QOQ | -5.39 | 0.84 | -84.42 | |
| EPS QOQ | -3.04 | 1.00 | -66.96 | |
| FCF QOQ | -10.43 | 0.38 | -96.31 | |
| Revenue QOQ | 0.02 | -0.42 | 2042.20 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Balanced
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 63.84 | 129.41 | 102.71 | |
| Days Sales Outstanding (DSO) | 70.10 | 86.81 | 23.84 | |
| Inventory Turnover | 1.41 | 0.70 | -50.67 | |
| Debt/Capitalization | 0.30 | 0.23 | -23.94 | |
| Quick Ratio | 0.77 | 1.64 | 114.60 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 80.20 | 98.19 | 22.43 | |
| Cash | 7.58 | 17.50 | 130.83 | |
| Capex | -5.83 | -4.93 | 15.38 | |
| Free Cash Flow | -6.67 | -4.10 | 38.52 | |
| Revenue | 20.08 | 11.59 | -42.30 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Positive
Fundamentals
Financial Health
06 - Financial Health ·
Bad